Would you consider PMRT in patients with clinically node negative breast cancer found to have micrometastatic nodal disease after neoadjuvant chemotherapy?  

Would it matter if the patient did or did not have a pathologic CR in the breast?



Answer from: Radiation Oncologist at Community Practice
Comments
Radiation Oncologist at Mon Health
Thanks, very helpful.
Sign in or Register to read more

Answer from: Radiation Oncologist at Community Practice

Answer from: Radiation Oncologist at Community Practice